Perfuze, a medical device company dedicated to advancing stroke treatment through next-generation catheter technology, today announced it has received FDA 510(k) clearance for the Millipede88® ...
The Millipede88 aspiration catheter. [Image courtesy of Perfuze] Perfuze announced today that it received FDA 510(k) ...
Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...
The FDA approved the first pulsed field ablation (PFA) catheter, the PulseSelect PFA system, for the treatment of paroxysmal and persistent atrial fibrillation (Afib), Medtronic announced on Wednesday ...
ALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, ...
First-line treatment with catheter ablation is superior to drug therapy for reducing atrial fibrillation, according to five year results from the MANTRA-PAF trial presented for the first time at ESC ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke ...
Doctors in Greater Noida performed North India’s first PAND procedure to treat a young woman with long-standing PAH, improving symptoms and offering a minimally invasive option beyond medication.
A team of engineers and physicians has developed a steerable catheter that for the first time will give neurosurgeons the ability to steer the device in any direction they want while navigating the ...
Catheter Precision, Inc. has announced its first purchase order for the VIVO product from Sahlgrenska University Hospital in Sweden, which is the largest hospital in the country and has a substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results